NeuroOne Medical Technologies Corporation NMTC
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 96.07% | 120.89% | 103.77% | 250.36% | 69.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 96.07% | 120.89% | 103.77% | 250.36% | 69.00% |
| Cost of Revenue | 25.20% | 25.59% | 17.67% | 20.18% | -7.83% |
| Gross Profit | 358.30% | 267.86% | 228.19% | 179.24% | 73.36% |
| SG&A Expenses | 4.31% | -6.53% | -7.01% | -6.54% | -2.48% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 200.00% | 200.00% | 200.00% | -- | -- |
| Total Operating Expenses | 67.47% | 60.37% | 54.46% | 6.42% | -23.87% |
| Operating Income | -34.05% | -7.39% | -12.67% | 64.44% | 53.64% |
| Income Before Tax | -33.96% | -0.61% | 5.00% | 70.73% | 55.90% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -33.96% | -0.61% | 5.00% | 70.73% | 55.90% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -33.96% | -0.61% | 5.00% | 70.73% | 55.90% |
| EBIT | -34.05% | -7.39% | -12.67% | 64.44% | 53.64% |
| EBITDA | -36.15% | -7.72% | -13.02% | 65.94% | 54.87% |
| EPS Basic | 11.29% | 41.94% | 38.02% | 83.09% | 67.78% |
| Normalized Basic EPS | 30.14% | 51.46% | 39.57% | 81.68% | 62.20% |
| EPS Diluted | 6.01% | 40.75% | 37.05% | 82.87% | 67.59% |
| Normalized Diluted EPS | 30.37% | 51.47% | 39.58% | 81.67% | 62.19% |
| Average Basic Shares Outstanding | 44.82% | 67.83% | 58.11% | 50.01% | 41.04% |
| Average Diluted Shares Outstanding | 45.11% | 67.77% | 58.05% | 50.05% | 41.08% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |